Amarillo Gold - Eric Sprott.
Eric Sprott.
Source: Mining Weekly.
  • Eric Sprott has announced his voting support agreement for Hochschild’s acquisition of Amarillo Gold (AGC)
  • Sprott’s 2176423 Ontario Ltd. owns 17.7 per cent of Amarillo shares
  • The proposed acquisition comes at a 66-per-cent premium and is expected to close in Q1 2022 pending Amarillo shareholder approval
  • Amarillo is advancing two gold projects located near excellent infrastructure in mining-friendly states in Brazil
  • Amarillo Gold (AGC) closed up by 80 per cent trading at $0.405 per share

Eric Sprott has announced his voting support agreement for Hochschild’s acquisition of Amarillo Gold (AGC).

Sprott’s 2176423 Ontario Ltd. entered into the agreement as the owner of 68,300,000 Amarillo shares representing 17.7 per cent of the company.

Pursuant to the potential acquisition, each share of Amarillo will be exchanged for C$0.40 plus one share of a new Brazil-focused exploration company, Lavras Gold.

Lavras will be capitalized with $10 million in cash and hold all assets and rights with respect to the Lavras do Sul Gold Project.

The cash consideration represents a 66-per-cent premium over Amarillo shares’ 20-trading day volume-weighted average trading price.

The total transaction value is $164.5 million excluding Lavras’ asset value and $10 million in cash.

Amarillo management views the arrangement as a culmination of its exploration and development successes in Brazil while maintaining shareholder participation in upcoming exploration.

The arrangement is subject to the approval of Amarillo shareholders. A special meeting is expected to be held in early 2022 for this purpose.

Amarillo is advancing two gold projects located near excellent infrastructure in mining-friendly states in Brazil.

Amarillo Gold (AGC) closed up by 80 per cent trading at $0.405 per share.

More From The Market Online
stock market down

@ the Bell: TSX hits near-month high

The TSX rose near highs not seen in a month, but a split between indices capped gains as mining and energy were the only…

FSD Pharma submits MS treatment clinical trial for review in Australia

FSD Pharma (CSE:HUGE) submits its MS treatment's Phase-1 Multiple Ascending Doses Clinical Trial Application for ethics review in Australia.

Cloud DX signs fourth contract with a provincial health authority

Cloud DX (TSXV:CDX) signs its fourth contract with a provincial health authority for remote patient monitoring.

International Petroleum stock rallies on Q1 results

Canadian energy stock International Petroleum Corp. (TSX:IPCO) rose in Tuesday trading on its Q1 2024 financial...